Prihlásiť sa Zaregistrujte sa zadarmo

Návratnosť aktív spoločnosti Panbela Therapeutics

Aká je hodnota metriky Návratnosť aktív spoločnosti Panbela Therapeutics?

Hodnota metriky Návratnosť aktív spoločnosti Panbela Therapeutics Inc. je -182.15%

Aká je definícia metriky Návratnosť aktív?



Návratnosť aktív (Return on assets - ROA) je rentabilita aktív. Vypočíta sa vydelením celkového príjmu priemerom celkových aktív.

The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.

Návratnosť aktív spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Panbela Therapeutics

Čomu sa venuje spoločnosť Panbela Therapeutics?

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.

Firmy s metrikou návratnosť aktív podobnou spoločnosti Panbela Therapeutics